πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 423 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7101932

Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol)

Nektar Therapeutics AL, Corporation Β· Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7078496

Thioester-terminated water soluble polymers and method of modifying the N-terminus of a po

Nektar Therapeutics AL, Corporation Β· Granted Tue Jul 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7060259

Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

Nektar Therapeutics AL, Corporation Β· Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7056500

Polymer conjugates of opioid antagonists

Nektar Therapeutics AL, Corporation Β· Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7053150

Segmented polymers and their conjugates

Nektar Therapeutics AL, Corporation Β· Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7030278

Polyethylene(Glycol) derivatives with proximal reactive groups

Nektar Therapeutics AL, Corporation Β· Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7026440

Branched polymers and their conjugates

Nektar Therapeutics AL, Corporation Β· Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6992168

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics AL, Corporation Β· Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6946117

Stabilized preparations for use in nebulizers

Nektar Therapeutics Β· Granted Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6921527

Composition for pulmonary administration comprising a drug and a hydrophobic amino acid

Nektar Therapeutics Β· Granted Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6911197

N-maleimidyl polymer derivatives

Nektar Therapeutics AL, Corporation Β· Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6908963

Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide ther

Nektar Therapeutics AL, Corporation Β· Granted Tue Jun 21 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6899898

Induced phase transition method for the production of microparticles containing hydrophobi

Nektar Therapeutics Β· Granted Tue May 31 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6899867

Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)

Nektar Therapeutics AL, Corporation Β· Granted Tue May 31 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6896906

Storage stable powder compositions of interleukin-4 receptor

Nektar Therapeutics Β· Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6894025

Biologically active molecules having thiol moiety conjugated to polymers containing ethyl

Nektar Therapeutics AL, Corporation Β· Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6890518

Compositions of chemically modified insulin

Nektar Therapeutics Β· Granted Tue May 10 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6864350

Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound m

Nektar Therapeutics AL, Corporation Β· Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6860907

Method of particle formation

Nektar Therapeutics Β· Granted Tue Mar 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6838528

Multi-arm block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation Β· Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6838076

Pulmonary administration of chemically modified insulin

Nektar Therapeutics Β· Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6838075

Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation

Nektar Therapeutics Β· Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6835372

Compositions comprising an active agent

Nektar Therapeutics Β· Granted Tue Dec 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6825031

Storage of materials

Nektar Therapeutics Β· Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired